Medical Conference Schedule Sept. 2013 through March 2014

Biopharma Shares Multiple 2025 Catalysts
Source: Dr. Swayampakula Ramakanth (01/17/2025)

Innate Pharma SA's (IPHA:NASDAQ; IPH:Paris) long-term corporate strategy led to it recieving a Buy rating from H.C. Wainwright & Co.

read more >

Tech Innovator Achieves Breakthrough Multi-Market Success
Source: Streetwise Reports (01/15/2025)

Clean technology company BioLargo Inc. (BLGO:OTCQX) announces it had a "widely successful" and "transformative" 2024 and is looking forward to more revenue growth in 2025. Read why one expert thinks investors should be doubling down on the stock.

read more >

Advanced AI Solutions Deliver Hope for CNS Cancer Treatment
Source: Streetwise Reports (01/15/2025)

Rakovina Therapeutics Inc. (RKV:TSX.V) has identified AI-designed drug candidates targeting advanced cancer treatments with CNS penetration. Read more about how this breakthrough could redefine oncology innovation.

read more >

Pharma Innovator Reveals Groundbreaking Diabetes Treatment
Source: Jason Kolbert (01/10/2025)

Biomea Fusion Inc.'s (BMEA:NASDAQ) drug could capture a significant share of the diabetes market, given the large target population globally, D. Boral Capital Analyst Jason Kolbert writes in an updated research note. Read why his target price is nearly a nearly 3,000% increase per share.

read more >

Biotech Advances Breakthrough Cancer Treatment Results
Source: Francois Brisebois (01/10/2025)

Sensei Biotherapeutics Inc. (SNSE:NASDAQ) is "well-positioned" to provide a clinical update on its drug targeting advanced solid tumors, Solnerstotug, in 2Q 2025, Oppenehimer & Co. Analyst Francois Brisebois writes in an updated research note.

read more >